The dynamic gastric environment and its impact on drug and formulation behaviour
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Before being absorbed in the small intestine and/or colon, orally administered drugs inevitably need to pass through the stomach. Hence, it seems reasonable that the residence of a dosage form in the gastric environment, however brief it may be, may influence drug disposition further down the gastrointestinal tract and may potentially impact systemic exposure to a drug of interest. However, research efforts in the past mainly focused on drug disposition at the level of the intestine, i.e. the main site of absorption, hereby disregarding or oversimplifying the stomach's contribution to gastrointestinal drug disposition. In the first part of this review, the complexity of the stomach with regard to anatomy, physiology and gastric fluid composition is emphasized. Between-population differences in gastric functioning and physicochemical characteristics of gastric fluids are discussed. The second part of this review focuses on several of the processes to which a dosage form can be exposed during its passage through the stomach and the implications for gastrointestinal drug behaviour and systemic drug disposition. Finally, the influence of real-life dosing conditions on drug disposition is discussed in the context of the stomach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vantrappen, G., Janssens, J., Hellemans, J., & Ghoos, Y. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108740 · Cited by 815 · cited 2×
“This so-called ‘(Interdigestive) Migrating Motor Complex ((I)MMC)’ was first described in man by Vantrappen et al. in 1977 and has been the subject of extensive research ever since (Vantrappen et al., 1977).”
BackgroundINTERSTITIAL CELLS OF CAJAL AS PACEMAKERS IN THE GASTROINTESTINAL TRACT
Sanders, K. M., Koh, S. D., & Ward, S. M. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040504.094718 · Cited by 619 · cited 1×
“…of the distal stomach; an additional excitatory stimulus (neural, hormonal, pharmacological) is required on top of slow wave propagation in order to induce a gastric contraction (Deloose et al., 2012; Hasler, 2009; Morgan and Szurszewski, 1980; O'Connor and O'Morain, 2014; Sanders et al., 2006).”
BackgroundCharman, W. N., Porter, C. J. H., Mithani, S., & Dressman, J. B. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960085v · Cited by 617 · cited 1×
“In fasted state, gastric acid secretion rates ranging between 0.03 – 0.07 mEq H+.min-1 have been reported (Charman et al., 1997; Dubois et al., 1977).”
BackgroundInfluentialMudie, D. M., Murray, K., Hoad, C. L., Pritchard, S. E., Garnett, M. C., Amidon, G. L., Gowland, P. A., Spiller, R. C., Amidon, G. E., & Marciani, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500210c · Cited by 486 · cited 2×
“…volume in fasted, healthy volunteers, reporting mean residual volumes ranging between 31 - 45 mL, slightly higher than an earlier assessment by Dubois et al. in 1977 (24 ± 5 mL; Table 1) (Dubois et al., 1977; Goetze et al., 2009; Koziolek et al., 2014b; Mudie et al., 2014; Schiller et al., 2005).”
BackgroundInfluentialMeasurement of Gastric Functions During Digestion of Ordinary Solid Meals in Man
Malagelada, J.-R., Longstreth, G. F., Summerskill, W. H. J., & Go, V. L. W. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80010-8 · Cited by 338 · cited 2×
“In response to meal intake, secretion rates rise significantly in an effort to re-acidify gastric contents (Dubois et al., 1977; Malagelada et al., 1976; Szafran et al., 1978).”
BackgroundAnderson, B. J., van Lingen, R. A., Hansen, T. G., Lin, Y.-C., & Holford, N. H. G. (2002) · Anesthesiology · doi:10.1097/00000542-200206000-00012 · Cited by 240
Oral insulin delivery: how far are we?
Fonte, P., Araújo, F., Reis, S., & Sarmento, B. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700228 · Cited by 211
Comparison of the acid stability of azithromycin and erythromycin A
Fiese, E. F., & Steffen, S. H. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.39 · Cited by 197 · cited 1×
“For example, macrolide antibiotics rapidly degrade under acidic conditions (Fiese and Steffen, 1990; Kristl and Vrečer, 2000; Nakagawa et al., 1992).”
BackgroundLim, S., Kang, S. M., Shin, H., Lee, H. J., Won Yoon, J., Yu, S. H., Kim, S.-Y., Yoo, S. Y., Jung, H. S., Park, K. S., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1447 · Cited by 191
Past, Present, and Future Technologies for Oral Delivery of Therapeutic Proteins
Singh, R., Singh, S., & Lillard, J. W. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21183 · Cited by 186 · cited 3×
“intraluminal degradation due to gastric (and intestinal) peptidase activity and subsequently to poor bioavailability (Crane and Luntz, 1968; Fonte et al., 2013; Singh et al., 2008; Ziv and Bendayan, 2000).”
BackgroundGastroparesis and Parkinson’s disease: a systematic review
Heetun, Z. S., & Quigley, E. M. M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.12.004 · Cited by 182 · cited 3×
“Heetun et al. bundled relevant data on the effect of Parkinson’s disease on gastric emptying in a comprehensive review (Heetun and Quigley, 2012).”
BackgroundPabla, D., Akhlaghi, F., & Zia, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.10.008 · Cited by 124
Mitra, A., & Kesisoglou, F. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400256h · Cited by 108 · cited 1×
“In general, a rise in gastric pH is disadvantageous for poorly water soluble, weakly basic drugs as the presence of ionized drug in the stomach is reduced and dissolution is hampered, potentially leading to decreased intestinal absorption and bioavailability (Mitra and Kesisoglou, 2013).”
BackgroundVita, R., Saraceno, G., Trimarchi, F., & Benvenga, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2684 · Cited by 99
McArthur, K. E., & Feldman, M. (1989) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.1.51 · Cited by 56 · cited 1×
“…the influence of temperature on gastric emptying has been reached, as illustrated by the fact that McArthur et al. observed no difference in gastric emptying after infusing coffee of different temperatures (4°C, 37°C and 58°C) into the stomach of healthy volunteers (McArthur and Feldman, 1989).”
BackgroundBrancato, D., Scorsone, A., Saura, G., Ferrara, L., Di Noto, A., Aiello, V., Fleres, M., & Provenzano, V. (2014) · Endocrine Practice · doi:10.4158/ep13418.or · Cited by 44 · cited 1×
“…(mixture of ethanol and glycerol) containing the same daily dose, patients’ thyroid-stimulating-hormone levels dropped significantly, indicating that levothyroxine disposition is unaffected by an increase in gastric pH when administered as a solution (Brancato et al., 2014; Vita et al., 2014).”
Background
Cited by
Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist
Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar7047 · Cited by 553
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Self-citationFoundations of gastrointestinal-based drug delivery and future developments
Chu, J. N., & Traverso, G. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00539-w · Cited by 289
Recent advances in colon drug delivery systems
Arévalo-Pérez, R., Maderuelo, C., & Lanao, J. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.026 · Cited by 179
Levothyroxine therapy in gastric malabsorptive disorders
Virili, C., Brusca, N., Capriello, S., & Centanni, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.621616 · Cited by 52
“On the contrary, drugs absorption from the stomach is usually thought to be negligible, although a passive diffusion through the gastric wall has been hypothesized and proven for compounds such as ethanol and small neutral molecules (16).”
BackgroundInfluential
Metadata
- Authors
- Van Den Abeele, J., Rubbens, J., Brouwers, J., & Augustijns, P.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 96
- Pages
- 207-231
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2518186768
- Cited by
- 102
- References
- 16
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.